vs

Side-by-side financial comparison of Applied Therapeutics, Inc. (APLT) and Reborn Coffee, Inc. (REBN). Click either name above to swap in a different company.

Reborn Coffee, Inc. is the larger business by last-quarter revenue ($1.4M vs $1.0M, roughly 1.4× Applied Therapeutics, Inc.). Reborn Coffee, Inc. runs the higher net margin — -254.3% vs -1899.0%, a 1644.7% gap on every dollar of revenue. On growth, Applied Therapeutics, Inc. posted the faster year-over-year revenue change (719.7% vs 7.8%).

Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG (RFLB.S) and listed on the SIX Swiss Exchange in 2016.

Reborn Coffee, Inc. is a specialty coffee roaster and retailer that offers premium single-origin and blended roasted coffee beans, handcrafted espresso drinks, baked snacks and related merchandise. It operates brick-and-mortar cafe locations primarily across the United States, alongside direct-to-consumer online sales and wholesale distribution to foodservice partners, with a core focus on ethically sourced, high-quality coffee products.

APLT vs REBN — Head-to-Head

Bigger by revenue
REBN
REBN
1.4× larger
REBN
$1.4M
$1.0M
APLT
Growing faster (revenue YoY)
APLT
APLT
+711.9% gap
APLT
719.7%
7.8%
REBN
Higher net margin
REBN
REBN
1644.7% more per $
REBN
-254.3%
-1899.0%
APLT

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
APLT
APLT
REBN
REBN
Revenue
$1.0M
$1.4M
Net Profit
$-19.0M
$-3.4M
Gross Margin
Operating Margin
-1675.8%
-224.7%
Net Margin
-1899.0%
-254.3%
Revenue YoY
719.7%
7.8%
Net Profit YoY
72.3%
-379.3%
EPS (diluted)
$-0.13
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APLT
APLT
REBN
REBN
Q3 25
$1.0M
$1.4M
Q2 25
$0
$1.8M
Q1 25
$0
$1.7M
Q4 24
$-1.0K
$1.8M
Q3 24
$1.3M
Q2 24
$144.0K
$1.4M
Q1 24
$190.0K
$1.5M
Q4 23
$-667.0K
$1.4M
Net Profit
APLT
APLT
REBN
REBN
Q3 25
$-19.0M
$-3.4M
Q2 25
$-21.3M
$-5.3M
Q1 25
$-21.8M
$-2.2M
Q4 24
$44.0M
$-1.8M
Q3 24
$-719.7K
Q2 24
$2.9M
$-1.3M
Q1 24
$-83.9M
$-990.5K
Q4 23
$-37.7M
$-1.7M
Gross Margin
APLT
APLT
REBN
REBN
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
98.7%
Q4 23
94.3%
Operating Margin
APLT
APLT
REBN
REBN
Q3 25
-1675.8%
-224.7%
Q2 25
-240.2%
Q1 25
-100.2%
Q4 24
3302300.0%
-95.2%
Q3 24
-57.6%
Q2 24
-14194.4%
-97.4%
Q1 24
-11101.6%
-56.9%
Q4 23
3149.3%
-122.6%
Net Margin
APLT
APLT
REBN
REBN
Q3 25
-1899.0%
-254.3%
Q2 25
-291.0%
Q1 25
-129.4%
Q4 24
-4400700.0%
-100.0%
Q3 24
-57.2%
Q2 24
2012.5%
-95.9%
Q1 24
-44177.9%
-65.3%
Q4 23
5649.0%
-127.0%
EPS (diluted)
APLT
APLT
REBN
REBN
Q3 25
$-0.13
$-0.68
Q2 25
$-0.15
$-1.15
Q1 25
$-0.15
$-0.47
Q4 24
$0.52
$-0.28
Q3 24
$-0.30
Q2 24
$-0.13
$-0.48
Q1 24
$-0.67
$-0.60
Q4 23
$-0.40
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APLT
APLT
REBN
REBN
Cash + ST InvestmentsLiquidity on hand
$11.9M
$44.0K
Total DebtLower is stronger
$500.0K
Stockholders' EquityBook value
$-561.0K
$-3.4M
Total Assets
$34.4M
$6.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APLT
APLT
REBN
REBN
Q3 25
$11.9M
$44.0K
Q2 25
$30.4M
$77.9K
Q1 25
$50.8M
$777.1K
Q4 24
$79.4M
$158.2K
Q3 24
$105.9K
Q2 24
$122.2M
$617.1K
Q1 24
$146.5M
$70.3K
Q4 23
$49.9M
$164.3K
Total Debt
APLT
APLT
REBN
REBN
Q3 25
$500.0K
Q2 25
$500.0K
Q1 25
$500.0K
Q4 24
$500.0K
Q3 24
$500.0K
Q2 24
$500.0K
Q1 24
$500.0K
Q4 23
$500.0K
Stockholders' Equity
APLT
APLT
REBN
REBN
Q3 25
$-561.0K
$-3.4M
Q2 25
$17.4M
$-1.9M
Q1 25
$36.7M
$415.6K
Q4 24
$57.0M
$2.6M
Q3 24
$2.7M
Q2 24
$72.4M
$2.5M
Q1 24
$67.3M
$2.6M
Q4 23
$-17.1M
$846.4K
Total Assets
APLT
APLT
REBN
REBN
Q3 25
$34.4M
$6.2M
Q2 25
$37.3M
$6.4M
Q1 25
$56.9M
$8.1M
Q4 24
$86.7M
$7.8M
Q3 24
$9.6M
Q2 24
$127.8M
$10.5M
Q1 24
$151.2M
$10.9M
Q4 23
$54.8M
$9.3M
Debt / Equity
APLT
APLT
REBN
REBN
Q3 25
Q2 25
Q1 25
1.20×
Q4 24
0.19×
Q3 24
0.19×
Q2 24
0.20×
Q1 24
0.19×
Q4 23
0.59×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APLT
APLT
REBN
REBN
Operating Cash FlowLast quarter
$-18.4M
$-1.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APLT
APLT
REBN
REBN
Q3 25
$-18.4M
$-1.6M
Q2 25
$-20.3M
$-3.6M
Q1 25
$-28.6M
$464.6K
Q4 24
$-19.5M
$-132.6K
Q3 24
$-424.0K
Q2 24
$-22.6M
$-961.8K
Q1 24
$-18.9M
$-1.9M
Q4 23
$-17.0M
$-188.2K
Free Cash Flow
APLT
APLT
REBN
REBN
Q3 25
Q2 25
Q1 25
Q4 24
$-600.9K
Q3 24
$-424.0K
Q2 24
$-1.3M
Q1 24
$-2.9M
Q4 23
$-1.9M
FCF Margin
APLT
APLT
REBN
REBN
Q3 25
Q2 25
Q1 25
Q4 24
-33.8%
Q3 24
-33.7%
Q2 24
-95.3%
Q1 24
-192.4%
Q4 23
-137.1%
Capex Intensity
APLT
APLT
REBN
REBN
Q3 25
0.0%
Q2 25
Q1 25
Q4 24
26.3%
Q3 24
0.0%
Q2 24
25.2%
Q1 24
65.0%
Q4 23
123.2%
Cash Conversion
APLT
APLT
REBN
REBN
Q3 25
Q2 25
Q1 25
Q4 24
-0.44×
Q3 24
Q2 24
-7.80×
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APLT
APLT

Segment breakdown not available.

REBN
REBN

Stores$1.1M83%
Other$229.9K17%

Related Comparisons